Drug Trial Radar · NCT04636814
A 52-week, Placebo- and Active- Controlled (Roflumilast, Daliresp® 500µg) Study to Evaluate the Efficacy and Safety of Two Doses of CHF6001 DPI (Tanimilast) as add-on to Maintenance Triple Therapy in Subjects With COPD and Chronic Bronchitis. (PILLAR)
Last checked: Nov 19, 2026Latest source record: Feb 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
3,973
Actual
Start
Jul 12, 2021
Primary completion
Dec 23, 2025
Study completion Dec 23, 2025
Sponsor
- Lead sponsor
- Chiesi Farmaceutici S.p.A.Industry
- Sponsor type
- Industry
- First posted
- Nov 19, 2020
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 40 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the efficacy and the safety of two doses of CHF6001 (Tanimilast) as add-on to maintenance triple therapy in the target patient population.
Conditions
- Chronic Obstructive Pulmonary Disease
Interventions
CHF6001 1600µgDrug
CHF6001 400µg, 2 inhalations bid (total daily dose of 1600µg) and Roflumilast matching placebo, 1 tablet once daily
CHF6001 3200µgDrug
CHF6001 800µg, 2 inhalations bid (total daily dose of 3200µg) and Roflumilast matching placebo, 1 tablet once daily
PlaceboDrug
CHF6001 matching placebo, 2 inhalations bid and Roflumilast matching placebo, 1 tablet once daily
RoflumilastDrug
\- 1 tablet of Roflumilast (Daliresp®), 250µg, once daily during the first 4 weeks of treatment then 1 tablet of Roflumilast (Daliresp®), 500µg, once daily for the remaining treatment period and CHF6001 matching placebo, 2 inhalations bid
Primary outcomes
What the sponsor says the trial is designed to measure.
- The number of moderate and severe exacerbations occurring during the planned 52-week treatment period.Time frame: Up to 52 weeks
Locations
460 sites in 28 countries. Site status is shown where the registry gives one.
Chiesi Clinical Trial - Site 840635
Andalusia, Alabama
Chiesi Clinical Trial - Site 840614
Foley, Alabama
Chiesi Clinical Trial - Site 840670
Guntersville, Alabama
Chiesi Clinical Trial - Site 840720
Mobile, Alabama
Chiesi Clinical Trial - Site 840643
Saraland, Alabama
Chiesi Clinical Trial - Site 840638
Phoenix, Arizona
Chiesi Clinical Trial - Site 840684
Conway, Arkansas
Chiesi Clinical Trial - Site 840675
Laguna Hills, California
Chiesi Clinical Trial - Site 840666
Los Angeles, California
Chiesi Clinical Trial - Site 840511
Newport Beach, California
Chiesi Clinical Trial - Site 840680
Northridge, California
Chiesi Clinical Trial - Site 840605
Northridge, California
Chiesi Clinical Trial - Site 840700
Pomona, California
Chiesi Clinical Trial - Site 840531
Westminster, California
Chiesi Clinical Trial - Site 840636
Centennial, Colorado
Chiesi Clinical Trial - Site 840688
Lakewood, Colorado
Chiesi Clinical Trial - Site 840735
Brooksville, Florida
Chiesi Clinical Trial - Site 840513
Chiefland, Florida
Chiesi Clinical Trial - Site 840652
Clearwater, Florida
Chiesi Clinical Trial - Site 840569
Clearwater, Florida
Chiesi Clinical Trial - Site 840545
Coral Gables, Florida
Chiesi Clinical Trial - Site 840603
Cutler Bay, Florida
Chiesi Clinical Trial - Site 840587
Cutler Bay, Florida
Chiesi Clinical Trial - Site 840568
Cutler Bay, Florida
Chiesi Clinical Trial - Site840539
Daytona Beach, Florida
Chiesi Clinical Trial - Site 840554
DeBary, Florida
Chiesi Clinical Trial - Site 840625
Doral, Florida
Chiesi Clinical Trial - Site 840572
Doral, Florida
Chiesi Clinical Trial - Site 840685
Hialeah, Florida
Chiesi Clinical Trial - Site 840504
Hialeah, Florida
Chiesi Clinical Trial - Site 840639
Hialeah, Florida
Chiesi Clinical Trial - Site 840582
Hialeah, Florida
Chiesi Clinical Trial - Site 840617
Hialeah, Florida
Chiesi Clinical Trial - Site 840514
Hialeah, Florida
Chiesi Clinical Trial - Site 840637
Hialeah Gardens, Florida
Chiesi Clinical Trial - Site 840509
Hollywood, Florida
Chiesi Clinical Trial - Site 840730
Hollywood, Florida
Chiesi Clinical Trial - Site 840565
Homestead, Florida
Chiesi Clinical Trial - Site 840674
Loxahatchee Groves, Florida
Chiesi Clinical Trial - Site 840732
Melbourne, Florida
Showing 40 of 460 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.